In synopsis, the present study demonstrates that acute treatment with (-)-phenserine, a centrally active AChE inhibitor that has proven well tolerated and active in AD clinical trials [31], [32], increased animal survival following soman exposure in a well characterized rodent model. The gene discussed is ACHE; the disease is Alzheimer disease.